A Phase 2 interventional study of Probiotic and Placebo in Stress, Psychological and Healthy, sponsored by Danisco. Completed at 7 sites in 2 countries. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-25.
Sponsored by Danisco (part of International Flavors & Fragrances Inc.) · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Stress, Psychological with a site in United Kingdom — 3 open to participants now, 3 under way, none of them phase 3. Stress, Psychological · United Kingdom.
Among the 30 studies in Stress, Psychological with a site in United Kingdom, this one is the 3rd largest by enrollment of the 28 interventional ones that give a count, is one of 5 that started in 2019, is the only one in phase 2, and was the 11th registered.
850 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.
Browse Stress, Psychological studies →3 of the 30 studies in Stress, Psychological with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Birmingham · Sites in United Kingdom
Ages 18–40 · Healthy volunteers
Royal Cornwall Hospitals Trust · Sites in United Kingdom
Ages 18+ · Healthy volunteers
University of Reading · Sites in United Kingdom
Ages 18–50 · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 76 Stress, Psychological studies recruiting now, 35 (46%) set no upper age limit and 37 (49%) stop at 75 or younger; 14 take children under 18; 50 take healthy volunteers.
This study: 18 Years to 40 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 5 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 190 is above the median of 84 across 694 interventional studies indexed under Stress, Psychological.
Median enrollment 42 across the 28 interventional studies, 270 across the 2 observational. Of the 22 that completed or were terminated, 2 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 30 have an industry lead sponsor. The 10 most frequent:
This study is registered under Danisco, one of the names counted as International Flavors & Fragrances Inc.. Under that name alone:
Danisco is the lead sponsor of 24 studies on the registry; 2 are open to participants now.
International Flavors & Fragrances Inc. has 1 study filed under Stress, Psychological — fewer than ten, so there is no comparison to draw.
1 of the studies in Stress, Psychological with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07871682University of ReadingFunctional Foods for Health | 2027-04-01 |
Add it to your calendar (.ics) → With an account.
Among the 30 studies in Stress, Psychological with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this clinical trial is to determine whether Probiotic can modulate the psychological stress experienced by healthy medical, dental and health science students preparing for university/institute of technology semester examination (s), measured by self-report scales and hypothalamic pituitary adrenal axis activity, compared with placebo.
The purpose of this clinical trial is to determine whether Probiotic can modulate the psychological stress experienced by healthy medical, dental and health science students preparing for university/institute of technology semester examination (s), measured by self-report scales and hypothalamic pituitary adrenal axis activity, compared with placebo.
The target group of the proposed study will consist of stress vulnerable / sensitive, healthy male and female adult participants currently enrolled in medical, dental or health science university course that are experiencing psychological stress induced by preparation for university/institute of technology semester examination (s).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Probiotic
Biological: Probiotic
Placebo
Other: Placebo
Probiotic
Placebo
State Trait Anxiety Inventory (STAI)-state total score
Absolute change in STAI-state total score between the active versus placebo group
Time frame: from baseline to 8 weeks
Change in Cortisol awakening response (CAR)
The absolute changes in the CAR will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in perceived stress (Visual Analog Scale (VAS)-stress)
The absolute change in VAS-stress score will be analyzed in the same fashion as described for the primary variable. * Visual Analog Scale (VAS)-stress. * Participants indicate on a 100mm line how stressed they perceived themselves to be over the last week. The scale is anchored from 0 = felt not stressed at all to 100 = felt highly stressed. Scores are determined by measuring from the left end to the mark using a ruler.
Time frame: from baseline to 8 weeks
Change in DASS-21, depression scale score from baseline (Visit 3) to 8 weeks (Visit 5)
The absolute changes in DASS-21, depression scale score will be analyzed in the same fashion as described for the primary variable. * Depression, anxiety, stress scale (21 items). * The DASS gives information about negative emotional states of depression, anxiety and stress. The questionnaire includes 3 scales (depression, anxiety and stress) of which each scale includes 7 items that are divided into subscales of 2-5 items of similar content.
Time frame: from baseline to 8 weeks
Change in DASS-21, anxiety scale score from baseline (Visit 3) to 8 weeks (Visit 5)
The absolute changes in DASS-21, anxiety scale score will be analyzed in the same fashion as described for the primary variable. * Depression, anxiety, stress scale (21 items). * The DASS gives information about negative emotional states of depression, anxiety and stress. The questionnaire includes 3 scales (depression, anxiety and stress) of which each scale includes 7 items that are divided into subscales of 2-5 items of similar content.
Time frame: from baseline to 8 weeks
Change in DASS-21, stress scale score from baseline (Visit 3) to 8 weeks (Visit 5)
The absolute changes in DASS-21, stress scale score will be analyzed in the same fashion as described for the primary variable. * Depression, anxiety, stress scale (21 items). * The DASS gives information about negative emotional states of depression, anxiety and stress. The questionnaire includes 3 scales (depression, anxiety and stress) of which each scale includes 7 items that are divided into subscales of 2-5 items of similar content.
Time frame: from baseline to 8 weeks
Change in HADS, depression score from baseline (Visit 3) to 8 weeks (Visit 5)
The absolute changes in HADS, depression score will be analyzed in the same fashion as described for the primary variable. * Hospital anxiety and depression scale. * The HADS is a 14 item self-report screening tool which is widely used in the clinic to assess levels of depression and anxiety.
Time frame: from baseline to 8 weeks
Change in HADS, anxiety score from baseline (Visit 3) to 8 weeks (Visit 5)
The absolute changes in HADS, anxiety score will be analyzed in the same fashion as described for the primary variable. * Hospital anxiety and depression scale. * The HADS is a 14 item self-report screening tool which is widely used in the clinic to assess levels of depression and anxiety.
Time frame: from baseline to 8 weeks
Change in PSS, total score from baseline (Visit 3) to 8 weeks (Visit 5)
The absolute changes in PSS, total score will be analyzed in the same fashion as described for the primary variable. * Cohen's perceived stress scale. * The PSS is a self-report measure in which participants rate, on a 5-point scale ranging from 0 (never) to 4 (very often), how often they have particular thoughts or feelings described by each of the 10 items. * Scores range from 0-40, with higher scores indicating greater stress over the previous month.
Time frame: from baseline to 8 weeks
Change in BL-VAS, alertness score from baseline (Visit 3) to 8 weeks (Visit 5)
The absolute changes in BL-VAS, alertness score will be analyzed in the same fashion as described for the primary variable. * Bond-Lader visual analogue scale. * The Bond-Lader VAS consist of 16 scales with anchors of related mood/ arousal dimensions (e.g. calm-excited; strong-feeble). * Participants indicate on a 100mm line how they feel along each mood dimension at that specific time, and scores from the 16 scales are converted into three composite mood/ arousal dimensions; alertness, calmness and contentedness.
Time frame: from baseline to 8 weeks
Change in BL-VAS, contentment score
The absolute changes in BL-VAS, contentment score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in BL-VAS, calmness score
The absolute changes in BL-VAS, calmness score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in Pittsburgh Sleep Quality Index (PSQI), total score
The absolute changes in the PSQI, total score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in PSQI, duration of sleep score
The absolute changes in the PSQI, duration of sleep score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in PSQI, sleep disturbance score
The absolute changes in the PSQI, sleep disturbance score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in PSQI, sleep latency score
The absolute changes in the PSQI, sleep latency score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in PSQI, daytime dysfunction due to sleepiness score
The absolute changes in the PSQI, daytime dysfunction due to sleepiness score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in PSQI, sleep efficiency score
The absolute changes in the PSQI, sleep efficiency score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in PSQI, subjective sleep quality score
The absolute changes in the PSQI, subjective sleep quality score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in PSQI, use of medication sleep score
The absolute changes in the PSQI, use of medication sleep score will be analyzed in the same fashion as described for the primary variable.
Time frame: from baseline to 8 weeks
Change in evening cortisol
Evening cortisol: Participants will provide x1 saliva sample each evening during two consecutive working days at approximately 8pm prior to Visit 3, Visit 4, Visit 5 and Visit 6. Concentrations of cortisol will be assayed in saliva supernatants using ELISA kits specifically designed for cortisol quantification, following manufacturer's instructions.
Time frame: from baseline to 8 weeks
IPAQ-short, physical activity level score
Changes in International Physical Activity Questionnaire (IPAQ)-short, physical activity level score
Time frame: from baseline to 4 weeks, 8 weeks and 10 weeks
Detection of Probiotic in feces
Changes in detection of Probiotic in feces
Time frame: from baseline to 8 weeks
STAI-state
Changes in State-trait anxiety inventory (STAI)-state, total score
Time frame: from baseline to 4 weeks and 10 weeks
Changes in Cortisol awakening response (CAR)
Cortisol awakening response: Participants will provide x3 saliva samples each morning during two consecutive working days prior to Visit 3, Visit 4, Visit 5 and Visit 6. Concentrations of cortisol will be assayed in saliva supernatants using ELISA kits specifically designed for cortisol quantification, following manufacturer's instructions.
Time frame: from baseline to 4 weeks and 10 weeks
Changes in evening cortisol
Evening cortisol: Participants will provide x1 saliva sample each evening during two consecutive working days at approximately 8pm prior to Visit 3, Visit 4, Visit 5 and Visit 6. Concentrations of cortisol will be assayed in saliva supernatants using ELISA kits specifically designed for cortisol quantification, following manufacturer's instructions.
Time frame: from baseline to 4 weeks and 10 weeks
Changes in Visual Analog Scale (VAS)-stress (VAS-stress)
Visual Analog Scale (VAS)-stress (VAS-stress): Participants will complete the VAS-stress at clinic visits 2, 3, 4, 5 and 6. Participants indicate on a 100mm line how stressed they perceived themselves to be over the last week. The scale is anchored from 0 = felt not stressed at all to 100 = felt highly stressed. Scores are determined by measuring from the left end to the mark using a ruler.
Time frame: from baseline to 4 weeks and 10 weeks
Depression, anxiety, stress scale (21 items) (DASS-21)
* DASS-21, depression scale score * DASS-21, anxiety scale score * DASS-21, stress scale score Participants will complete the DASS-21 at clinic visits 2, 3, 4, 5 and 6. The DASS gives information about negative emotional states of depression, anxiety and stress. The questionnaire includes 3 scales (depression, anxiety and stress) of which each scale includes 7 items that are divided into subscales of 2-5 items of similar content.
Time frame: from baseline to 4 weeks and 10 weeks
Hospital anxiety and depression scale (HADS)
* HADS, depression score * HADS, anxiety score Participants will complete the HADS at clinic visit 2, 3, 4, 5 and 6. The HADS is a 14 item self-report screening tool which is widely used in the clinic to assess levels of depression and anxiety. It was developed as a tool for quick and easy use in a hospital setting, but has since been validated in primary care and in the community.
Time frame: from baseline to 4 weeks and 10 weeks
Cohen's perceived stress scale (PSS)
o PSS, total score Participants will complete the PSS at clinic visits 2, 3, 4, 5 and 6. The PSS is a self-report measure in which participants rate, on a 5-point scale ranging from 0 (never) to 4 (very often), how often they have particular thoughts or feelings described by each of the 10 items. Scores range from 0-40, with higher scores indicating greater stress over the previous month.
Time frame: from baseline to 4 weeks and 10 weeks
Bond-Lader visual analogue scale (BL-VAS)
* BL-VAS, alertness score * BL-VAS, contentment score * BL-VAS, calmness score Participants will complete the BL-VAS at clinic visits 2, 3, 4, 5 and 6. The Bond-Lader VAS consist of 16 scales with anchors of related mood/ arousal dimensions (e.g. calm-excited; strong-feeble). Participants indicate on a 100mm line how they feel along each mood dimension at that specific time, and scores from the 16 scales are converted into three composite mood/ arousal dimensions; alertness, calmness and contentedness.
Time frame: from baseline to 4 weeks and 10 weeks
Pittsburgh sleep quality index (PSQI)
* PSQI, total score; PSQI, duration of sleep score * PSQI, sleep disturbance score * PSQI, sleep latency score * PSQI, daytime dysfunction due to sleepiness score * PSQI, sleep efficiency score * PSQI, subjective sleep quality score * PSQI, use of medication sleep score Participants will complete the PSQI at clinic visits 2, 3, 4, 5 and 6. The PSQI assesses sleep quality over the prior month. It is a self-report measure comprised of 19 items which are designed to measure 7 key components indicating either problematic or non-problematic sleep; sleep latency, sleep duration, sleep efficiency, sleep disturbances, subjective sleep quality, use of sleep medication and daytime dysfunction due to sleep disturbance. Scores on each component are combined to give a global score. Scores ≥5 indicate significant disturbances of sleep during the prior month.
Time frame: from baseline to 4 weeks and 10 weeks
Fecal microbiota composition
Changes in fecal microbiota composition
Time frame: from baseline to 8 weeks
Compliance of study product
Compliance of study product * Participants will be asked to return the remaining study products to the study site at each visit during the intervention period (Visit 4, 5 and 6) for study product accountability and accurate determination of compliance throughout the intervention period. * A study product inventory (dispensing records) will be used by site staff to record all study product dispensed and returned.
Time frame: 10 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2019 to primary completion in Feb 2020, 5 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Probiotic